ADHD in the News 2020-07-09

The Treatment of Tics in Children with ADHD

At the 2020 Virtual Conference on Pediatric Health Care, Dawn Garzon Maaks, PhD, CPNP-PC, PMHS, FAANP, FAAN, the immediate past president of the National Association of Pediatric Nurse Practitioners and the associate professor at the University of Portland in the School of Nursing, discussed important elements in the diagnosis and treatment of tics in children with attention deficit hyperactivity disorder (ADHD).

Diagnosing ADHD in Children and Teens Following a Failure in First-line Medications

The diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) in children and teens can be a complex and unique challenge for primary care providers...Anxiety, depression, tics, or complex ADHD may be occurring, in which case treatment with ADHD medication may not be the correct approach and could also cause harmful adverse effects.

Should you be evaluated for ADHD? It’s not just a kid thing

If you are among the millions of adults in the U.S. who do not know they have attention-deficit/hyperactivity disorder (ADHD), the past several months of social distancing have been a particularly steep battle...It is a common misperception that ADHD, a neurodevelopmental disorder characterized by developmentally inappropriate levels of inattention, impulsivity and hyperactivity, only affects children.

Prodrug Therapy for ADHD

ADHD Experts discuss the mechanism of action and the delivery system of ADHD medications including Mydayis, Intuniv, and Vyvanse, and the affect they have on patients.

Treatments for ADHD: Efficacy and Safety Data

Timothy E. Wilens, MD, explains the effectiveness and safety of stimulant medications, and the outcomes of long-term studies on these treatments for ADHD.

Coping With Adult ADHD During COVID-19

Throughout the COVID-19 shelter-in-place mandates and in this early phase of business re-openings, adults with ADHD have struggled to manage their personal lives and household circumstances in this ongoing haze of uncertainty. Many of the typical coping strategies for managing ADHD are still relevant but must be adapted to the new demands of working, learning and/or teaching, and living at home during the Pandemic.

IES Awards Lehigh Researchers $3.29 Million to Examine ADHD Behavioral Parent Education Program

Researchers from Lehigh’s College of Education and Lehigh’s College of Business have been awarded a $3.29 million grant from the U.S. Department of Education’s Institute of Education Sciences (IES) to examine the effects of face-to-face and online behavioral parent education for young children at-risk for Attention-Deficit/Hyperactivity Disorder (ADHD).

Investigational ADHD Drug Outperforms Placebo in Adults

Centanafadine, a novel investigational compound for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults, demonstrated statistically significant improvements compared with placebo in a pair of 6-week, phase 3 clinical trials, announced maker Otsuka Pharmaceutical Co. Ltd. and its US subsidiary Otsuka Pharmaceutical Development & Commercialization, Inc.